Interferon Therapy

Best Predictor for Sustained Response in Transient Responders is Viral Load

Published in Hepatitis Weekly, February 5th, 2001

- by Sonia Nichols, staff medical writer -- The best predictor for sustained response to a second round of interferon in patients with a transient biochemical response after initial treatment is pre-treatment viral loads.

This is according to researchers in Japan, who studied biochemical response to interferon therapy in 30 hepatitis C patients who were not sustained responders after initial interferon therapy.

While interferon is an effective treatment for many patients with chronic hepatitis C, others who take it will not respond to therapy at all, or will relapse with signs of transient biochemical response. This second group, the transient...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-02-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry